• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

活化的磷脂酰肌醇-3-激酶-δ 综合征中的疱疹病毒。

Herpesviruses in the Activated Phosphatidylinositol-3-Kinase-δ Syndrome.

机构信息

Medical Virology Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States.

出版信息

Front Immunol. 2018 Feb 23;9:237. doi: 10.3389/fimmu.2018.00237. eCollection 2018.

DOI:10.3389/fimmu.2018.00237
PMID:29599765
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5863522/
Abstract

The phosphatidylinositol-3-kinase (PI3K)/Akt pathway is important for multiple stages of herpesvirus replication including virus entry, replication, latency, and reactivation. Recently, patients with gain-of-function mutations in the p110δ-catalytic subunit of PI3K or in the p85-regulatory subunit of PI3K have been reported. These patients have constitutively active PI3K with hyperactivation of Akt. They present with lymphoproliferation and often have infections, particularly recurrent respiratory infections and/or severe virus infections. The most frequent virus infections are due to Epstein-Barr virus (EBV) and cytomegalovirus (CMV); patients often present with persistent EBV and/or CMV viremia, EBV lymphoproliferative disease, or CMV lymphadenitis. No patients have been reported with CMV pneumonia, colitis, or retinitis. Other herpesvirus infections have included herpes simplex pneumonia, recurrent zoster, and varicella after vaccination with the varicella vaccine. Additional viral infections have included adenovirus viremia, severe warts, and extensive Molluscum contagiosum virus infection. The increased susceptibility to virus infections in these patients is likely due to a reduced number of long-lived memory CD8 T cells and an increased number of terminally differentiated effector CD8 T cells.

摘要

磷脂酰肌醇-3-激酶(PI3K)/Akt 途径对疱疹病毒复制的多个阶段都很重要,包括病毒进入、复制、潜伏和再激活。最近,已经报道了 p110δ-催化亚基或 PI3K 的 p85-调节亚基的 PI3K 获得性功能突变的患者。这些患者具有持续激活的 PI3K 和 Akt 的过度激活。他们表现为淋巴组织增生,并且经常发生感染,特别是复发性呼吸道感染和/或严重病毒感染。最常见的病毒感染是由 Epstein-Barr 病毒(EBV)和巨细胞病毒(CMV)引起的;患者通常表现为持续的 EBV 和/或 CMV 病毒血症、EBV 淋巴组织增生性疾病或 CMV 淋巴结炎。没有报道过 CMV 肺炎、结肠炎或视网膜炎的患者。其他疱疹病毒感染包括单纯疱疹肺炎、复发性带状疱疹和水痘疫苗接种后的水痘。其他病毒感染包括腺病毒病毒血症、严重疣和广泛的传染性软疣病毒感染。这些患者对病毒感染的易感性增加可能是由于长寿命记忆 CD8 T 细胞数量减少和终末分化效应 CD8 T 细胞数量增加所致。

相似文献

1
Herpesviruses in the Activated Phosphatidylinositol-3-Kinase-δ Syndrome.活化的磷脂酰肌醇-3-激酶-δ 综合征中的疱疹病毒。
Front Immunol. 2018 Feb 23;9:237. doi: 10.3389/fimmu.2018.00237. eCollection 2018.
2
Genetic Defects in Phosphoinositide 3-Kinase δ Influence CD8 T Cell Survival, Differentiation, and Function.磷酸肌醇 3-激酶 δ 的遗传缺陷影响 CD8 T 细胞的存活、分化和功能。
Front Immunol. 2018 Aug 2;9:1758. doi: 10.3389/fimmu.2018.01758. eCollection 2018.
3
Dominant-activating germline mutations in the gene encoding the PI(3)K catalytic subunit p110δ result in T cell senescence and human immunodeficiency.编码 PI(3)K 催化亚基 p110δ 的基因中的显性激活种系突变导致 T 细胞衰老和人类免疫缺陷。
Nat Immunol. 2014 Jan;15(1):88-97. doi: 10.1038/ni.2771. Epub 2013 Oct 28.
4
Activating PIK3CD mutations impair human cytotoxic lymphocyte differentiation and function and EBV immunity.激活 PIK3CD 突变会损害人类细胞毒性淋巴细胞的分化和功能,并影响 EBV 免疫。
J Allergy Clin Immunol. 2019 Jan;143(1):276-291.e6. doi: 10.1016/j.jaci.2018.04.030. Epub 2018 May 22.
5
Enhanced AKT Phosphorylation of Circulating B Cells in Patients With Activated PI3Kδ Syndrome.活化的 PI3Kδ 综合征患者循环 B 细胞中 AKT 的磷酸化增强。
Front Immunol. 2018 Apr 5;9:568. doi: 10.3389/fimmu.2018.00568. eCollection 2018.
6
[Clinical and immunological analysis of patients with activated phosphoinositide 3-kinase δ syndrome resulting from PIK3CD mutation].[PIK3CD 突变导致的活化磷脂酰肌醇 3 - 激酶δ综合征患者的临床和免疫学分析]
Zhonghua Er Ke Za Zhi. 2017 Jan 2;55(1):19-24. doi: 10.3760/cma.j.issn.0578-1310.2017.01.004.
7
Serologic Status of Routine Childhood Vaccines, Cytomegalovirus, and Epstein-Barr Virus in Children With Inflammatory Bowel Disease.炎症性肠病患儿常规儿童疫苗、巨细胞病毒和 Epstein-Barr 病毒的血清学状态。
Inflamm Bowel Dis. 2019 Jun 18;25(7):1218-1226. doi: 10.1093/ibd/izy366.
8
Exhaustion of the CD8 T Cell Compartment in Patients with Mutations in Phosphoinositide 3-Kinase Delta.磷酸肌醇 3-激酶 δ 突变患者的 CD8 T 细胞区室耗竭。
Front Immunol. 2018 Mar 7;9:446. doi: 10.3389/fimmu.2018.00446. eCollection 2018.
9
Respiratory Manifestations of the Activated Phosphoinositide 3-Kinase Delta Syndrome.活化的磷酯酰肌醇 3-激酶 δ 综合征的呼吸表现。
Front Immunol. 2018 Mar 5;9:338. doi: 10.3389/fimmu.2018.00338. eCollection 2018.
10
Conformational disruption of PI3Kδ regulation by immunodeficiency mutations in and .通过[具体基因1]和[具体基因2]中的免疫缺陷突变对PI3Kδ调节的构象破坏。
Proc Natl Acad Sci U S A. 2017 Feb 21;114(8):1982-1987. doi: 10.1073/pnas.1617244114. Epub 2017 Feb 6.

引用本文的文献

1
EBV-positive diffuse large B cell lymphoma secondary to activated phosphoinositide 3 kinase δ syndrome type 1 (APDS1): a case report and literature review.1型活化磷脂酰肌醇3激酶δ综合征(APDS1)继发的EBV阳性弥漫性大B细胞淋巴瘤:一例报告及文献复习
Front Immunol. 2025 May 8;16:1583405. doi: 10.3389/fimmu.2025.1583405. eCollection 2025.
2
Overlapping Clinical Phenotypes in Patients with Primary Ciliary Dyskinesia or Activated Phosphoinositide 3-Kinase Delta Syndrome.原发性纤毛运动障碍或活化磷脂酰肌醇3-激酶δ综合征患者的重叠临床表型
J Pediatr. 2025 May;280:114499. doi: 10.1016/j.jpeds.2025.114499. Epub 2025 Feb 6.
3
Expert insights on Hodgkin's lymphoma development in an activated PI3K delta syndrome patient undergoing leniolisib treatment.对一名接受来尼利西布治疗的活化磷脂酰肌醇-3-激酶δ综合征患者霍奇金淋巴瘤发展情况的专家见解。
Front Immunol. 2025 Jan 13;15:1517543. doi: 10.3389/fimmu.2024.1517543. eCollection 2024.
4
The immunogenetic basis of severe herpes simplex infections in neonates and children: a review.新生儿和儿童严重单纯疱疹感染的免疫遗传学基础:综述
Pediatr Res. 2025 Jan 18. doi: 10.1038/s41390-025-03830-7.
5
Report of the Italian Cohort with Activated Phosphoinositide 3-Kinase δ Syndrome in the Target Therapy Era.靶向治疗时代意大利活化磷脂酰肌醇3-激酶δ综合征队列报告。
J Clin Immunol. 2024 Dec 23;45(1):58. doi: 10.1007/s10875-024-01835-1.
6
Decoding Critical Targets and Signaling Pathways in EBV-Mediated Diseases Using Large Language Models.使用大型语言模型解码 EBV 介导疾病中的关键靶标和信号通路。
Viruses. 2024 Oct 24;16(11):1660. doi: 10.3390/v16111660.
7
[Activated phosphoinositide 3-kinase delta syndrome: report of seven cases].[活化磷脂酰肌醇3-激酶δ综合征:7例报告]
Zhongguo Dang Dai Er Ke Za Zhi. 2024 May 15;26(5):499-505. doi: 10.7499/j.issn.1008-8830.2312065.
8
PI3Kδ Pathway Dysregulation and Unique Features of Its Inhibition by Leniolisib in Activated PI3Kδ Syndrome and Beyond.PI3Kδ 通路失调及 Leniolisib 对其的抑制作用在活化的 PI3Kδ 综合征及其他疾病中的独特特征。
J Allergy Clin Immunol Pract. 2024 Jan;12(1):69-78. doi: 10.1016/j.jaip.2023.09.016. Epub 2023 Sep 28.
9
A randomized, placebo-controlled phase 3 trial of the PI3Kδ inhibitor leniolisib for activated PI3Kδ syndrome.一项针对激活的 PI3Kδ 综合征的 PI3Kδ 抑制剂 leniolisib 的随机、安慰剂对照 3 期试验。
Blood. 2023 Mar 2;141(9):971-983. doi: 10.1182/blood.2022018546.
10
Host Defenses to Viruses: Lessons from Inborn Errors of Immunity.宿主抗病毒防御:固有免疫缺陷相关启示。
Medicina (Kaunas). 2022 Feb 7;58(2):248. doi: 10.3390/medicina58020248.

本文引用的文献

1
Effective "activated PI3Kδ syndrome"-targeted therapy with the PI3Kδ inhibitor leniolisib.使用PI3Kδ抑制剂来那度胺进行有效的“活化PI3Kδ综合征”靶向治疗。
Blood. 2017 Nov 23;130(21):2307-2316. doi: 10.1182/blood-2017-08-801191. Epub 2017 Sep 29.
2
Early diagnosis of PI3Kδ syndrome in a 2 years old girl with recurrent otitis and enlarged spleen.2 岁女童反复中耳炎伴脾大,提示早发型 PI3Kδ 综合征
Immunol Lett. 2017 Oct;190:279-281. doi: 10.1016/j.imlet.2017.08.021. Epub 2017 Aug 31.
3
The PI3K Pathway in Human Disease.人类疾病中的PI3K信号通路。
Cell. 2017 Aug 10;170(4):605-635. doi: 10.1016/j.cell.2017.07.029.
4
Aged-associated cytomegalovirus and Epstein-Barr virus reactivation and cytomegalovirus relationship with the frailty syndrome in older women.老年相关的巨细胞病毒和爱泼斯坦-巴尔病毒再激活以及老年女性中巨细胞病毒与衰弱综合征的关系。
PLoS One. 2017 Jul 10;12(7):e0180841. doi: 10.1371/journal.pone.0180841. eCollection 2017.
5
Variant PIK3R1 Hypermorphic Mutation and Clinical Phenotypes in a Family with Short Statures, Mild Immunodeficiency and Lymphoma.一个身材矮小、轻度免疫缺陷和淋巴瘤家族中的PIK3R1变异型超显性突变及临床表型
Klin Padiatr. 2017 May;229(3):113-117. doi: 10.1055/s-0043-104218. Epub 2017 May 30.
6
Persistent Impairment of T-Cell Regeneration in a Patient with Activated PI3K δ Syndrome.一名患有活化PI3Kδ综合征患者的T细胞再生持续受损。
J Clin Immunol. 2017 May;37(4):347-350. doi: 10.1007/s10875-017-0393-7. Epub 2017 Apr 21.
7
Novel PIK3CD mutations affecting N-terminal residues of p110δ cause activated PI3Kδ syndrome (APDS) in humans.影响p110δ N端残基的新型PIK3CD突变导致人类激活型PI3Kδ综合征(APDS)。
J Allergy Clin Immunol. 2017 Oct;140(4):1152-1156.e10. doi: 10.1016/j.jaci.2017.03.026. Epub 2017 Apr 13.
8
Mutations in PIK3R1 can lead to APDS2, SHORT syndrome or a combination of the two.PIK3R1 突变可导致 APDS2、SHORT 综合征或两者的组合。
Clin Immunol. 2017 Jun;179:77-80. doi: 10.1016/j.clim.2017.03.004. Epub 2017 Mar 14.
9
Abnormal B-cell maturation in the bone marrow of patients with germline mutations in PIK3CD.患者种系 PIK3CD 突变的骨髓中异常 B 细胞成熟。
J Allergy Clin Immunol. 2017 Mar;139(3):1032-1035.e6. doi: 10.1016/j.jaci.2016.08.028. Epub 2016 Sep 30.
10
Clinical spectrum and features of activated phosphoinositide 3-kinase δ syndrome: A large patient cohort study.活化磷脂酰肌醇3-激酶δ综合征的临床谱和特征:一项大型患者队列研究。
J Allergy Clin Immunol. 2017 Feb;139(2):597-606.e4. doi: 10.1016/j.jaci.2016.06.021. Epub 2016 Jul 16.